Freenome Inc.

Last updated September 27, 2026
Favorite this organization

Organization details

Legal name
Freenome Inc.
Former names
Perceptive Capital Solutions Corp
Ownership
Public
Status
Active
SIC code
8071 — Services-Medical Laboratories
Jurisdiction of incorporation
Delaware
Headquarters city
Brisbane
Headquarters state / province
California
Headquarters country
United States
Fiscal year end
December
Ticker symbol
FRNM
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0002017526

Board of directors

Follow this board

Chief executives

Aaron Matthew Elliott · Chief Executive Officer
Since July 2026
Adam Leo Stone · Chief Executive Officer
2024 – 2026 · Former

Board connections

9 of this board's directors also sit on 38 other boards.

Network of Freenome Inc.'s board connections Solid Biosciences Inc. Solid Biosciences Inc. ARS Pharmaceuticals Inc. ARS Pharmaceuticals In... Acrivon Therapeutics Inc. Acrivon Therapeutics I... Acumen Pharmaceuticals Inc. Acumen Pharmaceuticals... Artiva Biotherapeutics Inc. Artiva Biotherapeutics... Bicara Therapeutics Inc. Bicara Therapeutics In... Black Diamond Therapeutics Inc. Black Diamond Therapeu... Climb Bio Inc. Climb Bio Inc. Evommune Inc. Evommune Inc. Hemab Therapeutics Holdings Inc. Hemab Therapeutics Hol... Immatics N.V. Immatics N.V. Jade Biosciences Inc. Jade Biosciences Inc. Janux Therapeutics Inc. Janux Therapeutics Inc... LENZ Therapeutics Inc. LENZ Therapeutics Inc. Mineralys Therapeutics Inc. Mineralys Therapeutics... Nautilus Biotechnology Inc. Nautilus Biotechnology... Adam Leo Stone Adam Leo Stone Joseph Edelman Joseph Edelman Michael Seth Altman Michael Seth Altman Peter Kolchinsky Peter Kolchinsky Rajeev M. Shah Rajeev M. Shah Freenome Inc.
Shared director Other board Same sector +22 more in the list below

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$0
0 purchases by 0 insiders
Sold, last 12 months
$0
0 sales by 0 insiders
Date Insider Transaction Shares Price Value
Sep 2, 2026 Aaron Matthew Elliott Director, Officer (Chief Executive Officer) Shares withheld for tax −71,920 $15.25 $1,096,780
Jul 20, 2026 Michael Seth Altman Former Dir, Ofc, 10% Ownr Derivative conversion +2,066,250 — —
Jul 20, 2026 PERCEPTIVE ADVISORS LLC 10% owner Grant or award +5,500,000 $10.00 $55,000,000
Jul 20, 2026 RA CAPITAL MANAGEMENT, L.P. Director, 10% owner Grant or award +6,561,711 — —
Jul 20, 2026 Adam Leo Stone Former Dir, Ofc, 10% Ownr Derivative conversion +2,066,250 — —
Jul 20, 2026 Mark C. McKenna Former Director Derivative conversion +30,000 — —
Jul 20, 2026 Perceptive Capital Solutions Holdings Former 10% Owner Derivative conversion +2,066,250 — —
Jul 20, 2026 Kenneth Song Former Director Derivative conversion +30,000 — —
Jul 20, 2026 Harlan Waksal Former Director Derivative conversion +30,000 — —
Jul 20, 2026 RA CAPITAL MANAGEMENT, L.P. Director, 10% owner Grant or award +970,950 — —
Jul 20, 2026 RA CAPITAL MANAGEMENT, L.P. Director, 10% owner Grant or award +553,703 — —
Jul 20, 2026 RA CAPITAL MANAGEMENT, L.P. Director, 10% owner Grant or award +908,103 — —
Jul 20, 2026 RA CAPITAL MANAGEMENT, L.P. Director, 10% owner Grant or award +367,427 — —
Jul 20, 2026 RA CAPITAL MANAGEMENT, L.P. Director, 10% owner Grant or award +4,918,411 $10.00 $49,184,110
Jul 20, 2026 RA CAPITAL MANAGEMENT, L.P. Director, 10% owner Grant or award +336,965 $10.00 $3,369,650

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.